Superoxide anion generation and lipid peroxidation processes during hemodialysis with reused cuprophan dialyzers.
In 11 chronic uremic patients superoxide anion (O2-.) generation and lipid peroxidation processes were determined during hemodialyses with cuprophan dialyzers used three times. Intradialytic changes observed during the first 20 min of hemodialysis, that is the period of the most marked alterations, with consecutive uses of the same dialyzer included: decreased whole blood O2-. generation at rest and following stimulation with opsonized zymosan, decreased reductions in the erythrocyte superoxide dismutase (SOD-1) activity, increased reductions in the plasma malonyldialdehyde (MDA) concentrations, and unchanged erythrocyte MDA concentrations. However, immediately before hemodialysis with third-used dialyzer whole blood O2-. generation at rest and following opsonized-zymosan stimulation, and erythrocyte SOD-1 activity were slightly, but statistically significantly, lower (p less than 0.05), while plasma MDA concentrations were higher (p less than 0.05) than those before hemodialysis with first-used dialyzer; erythrocyte MDA concentrations remained unchanged. The results seem to indicate that dialyzer reuse may exert beneficial effects on whole blood O2-. generation and protect erythrocyte membrane lipids from peroxidation, but, however, it leads to slightly increasing predialysis plasma lipid peroxidation.
Trznadel
K
K
2nd Department of Internal Medicine, Institute of Internal Medicine, WAM, Lódź, Poland.
Luciak
M
M
Pawlicki
L
L
Kedziora
J
J
Blaszczyk
J
J
Buczyński
A
A
D000328:Adult; D002482:Cellulose / Q000031:analogs & derivatives*; D004912:Erythrocytes / Q000378:metabolism; D005260:Female; D005609:Free Radicals; D006801:Humans; D015227:Lipid Peroxidation; D008297:Male; D008315:Malondialdehyde / Q000097:blood; D009895:Opsonin Proteins; D006435:Renal Dialysis / Q000295:instrumentation*; D013482:Superoxide Dismutase / Q000097:blood; D013481:Superoxides / Q000097:blood*; D014511:Uremia / Q000097:blood / Q000628:therapy*; D015054:Zymosan / Q000494:pharmacology
D005609:Free Radicals; D009895:Opsonin Proteins; D013481:Superoxides; D008315:Malondialdehyde; D002482:Cellulose; D015054:Zymosan; C009865:cuprammonium cellulose; D013482:Superoxide Dismutase